Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$537K Buy
15,863
+580
+4% +$18.6K 0.66% 52
2017
Q2
$487K Sell
15,283
-422
-3% -$13.3K 0.57% 56
2017
Q1
$510K Sell
15,705
-780
-5% -$24.6K 0.56% 55
2016
Q4
$508K Sell
16,485
-36,969
-69% -$1.13M 0.54% 57
2016
Q3
$1.69M Sell
53,454
-4,232
-7% -$142K 1.6% 17
2016
Q2
$1.93M Sell
57,686
-1,000
-2% -$31.9K 1.8% 10
2016
Q1
$1.65M Sell
58,686
-13,431
-19% -$384K 1.51% 21
2015
Q4
$2.21M Sell
72,117
-3,989
-5% -$125K 1.73% 12
2015
Q3
$2.27M Sell
76,106
-2,248
-3% -$72.1K 1.82% 8
2015
Q2
$2.49M Buy
78,354
+13,458
+21% +$439K 1.7% 11
2015
Q1
$2.14M Sell
64,896
-33,600
-34% -$1.07M 1.6% 8
2014
Q4
$2.91M Sell
98,496
-7,307
-7% -$210K 1.57% 11
2014
Q3
$2.97M Sell
105,803
-15,192
-13% -$426K 1.59% 11
2014
Q2
$3.41M Buy
120,995
+11,754
+11% +$335K 1.7% 6
2014
Q1
$3.33M Sell
109,241
-2,583
-2% -$77K 1.77% 6
2013
Q4
$3.25M Sell
111,824
-7,564
-6% -$220K 1.77% 6
2013
Q3
$3.25M Sell
119,388
-3,863
-3% -$105K 1.84% 4
2013
Q2
$3.27M Buy
+123,251
New +$3.41M 1.85% 4

Other funds holding PFE

Carl Domino's PFE Position: Q3 2017 in Review

Carl Domino increased its Pfizer (PFE) stake by 3.8% in Q3 2017, buying an estimated $18.6K and bringing the position to 15,863 shares worth $537K. The position accounts for 0.66% of the portfolio, ranked #52.

Carl Domino first reported a position in PFE in Q2 2013 and has held it in 18 quarters since. The position peaked at $3.41M in Q2 2014. 2,042 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

  • Carl Domino held 15,863 shares of Pfizer worth $537K as of Q3 2017.
  • Carl Domino bought 580 Pfizer shares in Q3 2017, an estimated $18.6K.
  • Pfizer made up 0.66% of Carl Domino's portfolio in Q3 2017, its #52 holding.
  • Carl Domino first reported a position in Pfizer in Q2 2013 and has held it in 18 quarters since.
  • Carl Domino's Pfizer position peaked at $3.41M in Q2 2014.
  • 2,042 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on Carl Domino's 13F filing for Q3 2017, filed 7 Nov 2017.